Diabetes Drug Focus of New Clinical Trial for Parkinson’s

Diabetes Drug Focus of New Clinical Trial for Parkinson’s
• A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as a potential therapy for Parkinson’s disease. • Patients and clinicians are urged to wait for the results of the trial. • The trial is part of the Linked Clinical Trials initiative, a program spearheaded by ... read more
Source: Published on 2016-09-12